This led to the assumption that 2-HG produced by mutant IDH1 can induce CIMP in a small proportion of BRAF-mutant MSS CRCs, a mechanism that was observed in glioblastoma and is associated with poor prognosis [132]. This evidence concerns the gene IDH1 and glioblastoma.